When Genzyme announced recently it was exploring a new deal structure to help resolve the impasse on price with bidder Sanofi-Aventis, it highlighted a great tool in the M&A world, the earn-out deal. They called the structure a CRV or Contingent Value Right, an...
Let’s face it the Private Equity (PE) Industry has had an atrocious run of bad PR over the last few years. Of course some players have been rightly “called out” for excessive leverage, over generous fees, weak commercial judgement including some pretty huge losses...
The US Census Bureau considers baby boomers to be those born between 1946 and 1964 or aged 45 to 63 in today’s currency! Many of these folk own businesses and will want to realize their life’s work over the next 5 years. A remarkable few will achieve their goal. Below...